Consistent with our present research study, our findings showed that patients with T2DM, both with and without cardiac dysfunction, and the CC genotype have reduced serum levels of HDL-C, ApoA1, and insulin sensitivity. The gene discussed is INS; the disease is type 2 diabetes mellitus.